Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial: Cambridge, UK Wednesday, April 22 ...

Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

Vera Clinic, internationally recognised as a leading centre of innovation in hair restoration surgery, has released the full ...

Certainly, cravings can get the best of us and in some cases too much of what we crave can result in some unhealthy outcomes.

NAB believes that with GPS increasingly recognized as a potential single point of failure, BPS has an important role to play.

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Earth Day, falling on 22 April this year, typically conjures images of tree-planting ceremonies and beach clean-ups. Worthy ...

As enterprises race to deploy autonomous AI agents, a growing concern has emerged around what these agents are permitted to ...

Certified trainer Chris Freytag has spent more than 35 years in the fitness industry, coaching women through the physical ...

It seeks to maintain a culture that prioritises work–life balance, with health and wellbeing forming a central part of its ...

A 129-foot wall of water crashes into a mist-filled basin, pulling you closer with every thunderous drop. This Northern ...